Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Treasury Shares (2016 - 2026)

Usana Health Sciences has reported Treasury Shares over the past 10 years, most recently at $875000.0 for Q1 2026.

  • Quarterly Treasury Shares rose 47.8% to $875000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $875000.0 through Jan 2026, up 47.8% year-over-year, with the annual reading at $875000.0 for FY2026, 47.8% up from the prior year.
  • Treasury Shares was $875000.0 for Q1 2026 at Usana Health Sciences, up from $592000.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $875000.0 in Q1 2026 and troughed at $12000.0 in Q4 2022.
  • The 4-year median for Treasury Shares is $490000.0 (2023), against an average of $467000.0.
  • Year-over-year, Treasury Shares tumbled 96.72% in 2022 and then soared 3983.33% in 2023.
  • A 4-year view of Treasury Shares shows it stood at $12000.0 in 2022, then soared by 3983.33% to $490000.0 in 2023, then rose by 20.82% to $592000.0 in 2024, then skyrocketed by 47.8% to $875000.0 in 2026.
  • Per Business Quant, the three most recent readings for USNA's Treasury Shares are $875000.0 (Q1 2026), $592000.0 (Q4 2024), and $490000.0 (Q4 2023).